title: Advances in management of follicular lymphoma.
authors.affiliation: Institute of Hematology "Seràgnoli" University of Bologna.
authors.forename: Pier Luigi
authors.initials: PL
authors.lastname: Zinzani
mesh_terms: D000814:Aniline Compounds / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D018951:Antigens, CD20 / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D064592:Autografts; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin; D055808:Drug Discovery; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008224:Lymphoma, Follicular / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D058990:Molecular Targeted Therapy; D009367:Neoplasm Staging; D011239:Prednisolone; D011241:Prednisone / Q000008:administration & dosage; D016499:Radioimmunotherapy; D000069283:Rituximab; D013449:Sulfonamides / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000814:Aniline Compounds; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D013449:Sulfonamides; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; C585832:pidilizumab; D011241:Prednisone; C528561:navitoclax